Ezgi Ilan

829 total citations
14 papers, 597 citations indexed

About

Ezgi Ilan is a scholar working on Radiology, Nuclear Medicine and Imaging, Epidemiology and Oncology. According to data from OpenAlex, Ezgi Ilan has authored 14 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Ezgi Ilan's work include Neuroendocrine Tumor Research Advances (8 papers), Medical Imaging Techniques and Applications (7 papers) and Lung Cancer Research Studies (7 papers). Ezgi Ilan is often cited by papers focused on Neuroendocrine Tumor Research Advances (8 papers), Medical Imaging Techniques and Applications (7 papers) and Lung Cancer Research Studies (7 papers). Ezgi Ilan collaborates with scholars based in Sweden, Israel and United States. Ezgi Ilan's co-authors include Mark Lubberink, Anders Sundin, Mattias Sandström, Ulrike Garske‐Román, William T. Peterson, David Hsu, Craig S. Levin, J. Uribe, Barbro Eriksson and Cecilia Wassberg and has published in prestigious journals such as Journal of Nuclear Medicine, Cancers and Neuroendocrinology.

In The Last Decade

Ezgi Ilan

14 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ezgi Ilan Sweden 9 470 209 162 146 125 14 597
Johanna Svensson Sweden 16 509 1.1× 355 1.7× 272 1.7× 142 1.0× 171 1.4× 38 792
A. Runz Germany 12 337 0.7× 289 1.4× 240 1.5× 311 2.1× 217 1.7× 38 747
Elisa Grassi Italy 13 369 0.8× 186 0.9× 172 1.1× 114 0.8× 89 0.7× 37 527
Emilio Mezzenga Italy 10 259 0.6× 117 0.6× 119 0.7× 101 0.7× 92 0.7× 38 404
Pablo Mínguez Gabiña Spain 9 442 0.9× 88 0.4× 67 0.4× 209 1.4× 35 0.3× 24 533
David Barker United States 7 271 0.6× 30 0.1× 46 0.3× 110 0.8× 58 0.5× 9 389
Helena Uusijärvi Sweden 8 233 0.5× 124 0.6× 111 0.7× 74 0.5× 81 0.6× 11 350
Lore Santoro France 11 310 0.7× 78 0.4× 91 0.6× 114 0.8× 34 0.3× 25 417
Türkay Toklu Türkiye 12 419 0.9× 100 0.5× 140 0.9× 60 0.4× 62 0.5× 39 540
Claudia Brogsitter Germany 11 204 0.4× 105 0.5× 104 0.6× 26 0.2× 57 0.5× 35 388

Countries citing papers authored by Ezgi Ilan

Since Specialization
Citations

This map shows the geographic impact of Ezgi Ilan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ezgi Ilan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ezgi Ilan more than expected).

Fields of papers citing papers by Ezgi Ilan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ezgi Ilan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ezgi Ilan. The network helps show where Ezgi Ilan may publish in the future.

Co-authorship network of co-authors of Ezgi Ilan

This figure shows the co-authorship network connecting the top 25 collaborators of Ezgi Ilan. A scholar is included among the top collaborators of Ezgi Ilan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ezgi Ilan. Ezgi Ilan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
3.
Lubberink, Mark, Helena Wilking, Ezgi Ilan, et al.. (2020). In Vivo Instability of 177Lu-DOTATATE During Peptide Receptor Radionuclide Therapy. Journal of Nuclear Medicine. 61(9). 1337–1340. 19 indexed citations
4.
Ilan, Ezgi, et al.. (2019). <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy: Dose Response in Small Intestinal Neuroendocrine Tumors. Neuroendocrinology. 110(7-8). 662–670. 35 indexed citations
5.
Ilan, Ezgi, Irina Velikyan, Mattias Sandström, Anders Sundin, & Mark Lubberink. (2019). Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using 68Ga-DOTATOC and 68Ga-DOTATATE. Journal of Nuclear Medicine. 61(2). 217–221. 25 indexed citations
6.
Sundin, Anders, Carlos Trampal, Lars Lindsjö, et al.. (2018). Evaluation of Penalized-Likelihood Estimation Reconstruction on a Digital Time-of-Flight PET/CT Scanner for18F-FDG Whole-Body Examinations. Journal of Nuclear Medicine. 59(7). 1152–1158. 60 indexed citations
7.
Hsu, David, Ezgi Ilan, William T. Peterson, et al.. (2017). Studies of a Next-Generation Silicon-Photomultiplier–Based Time-of-Flight PET/CT System. Journal of Nuclear Medicine. 58(9). 1511–1518. 181 indexed citations
8.
Sandström, Mattias, Ezgi Ilan, Anders Sundín, & Mark Lubberink. (2017). Is there a gender difference of absorbed dose to the risk organs in patients receiving 177Lu-Octreotate therapy?. 58. 2 indexed citations
9.
Sandström, Mattias, Ezgi Ilan, Anders Sundin, & Mark Lubberink. (2017). Image quality measurements with 177Lu on a GE Discovery 670 CZT. 58. 2 indexed citations
10.
Ilan, Ezgi, et al.. (2017). Performance comparison of three commercially available PET systems : SIGNA PET/MR, Discovery IQ and Discovery MI. 58. 2 indexed citations
11.
Lindsjö, Lars, Ezgi Ilan, Anders Sundin, et al.. (2017). Optimisation of penalized likelihood estimation reconstruction (Q.Clear) on a digital time-of-flight PET-CT scanner for four different PET tracers. 58. 2 indexed citations
12.
Ilan, Ezgi, Mattias Sandström, Irina Velikyan, et al.. (2016). Parametric Net Influx Rate Images of 68Ga-DOTATOC and 68Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast. Journal of Nuclear Medicine. 58(5). 744–749. 27 indexed citations
13.
Sandström, Mattias, Ezgi Ilan, Anna Karlberg, et al.. (2015). Method dependence, observer variability and kidney volumes in radiation dosimetry of 177Lu-DOTATATE therapy in patients with neuroendocrine tumours. EJNMMI Physics. 2(1). 24–24. 32 indexed citations
14.
Ilan, Ezgi, Mattias Sandström, Cecilia Wassberg, et al.. (2015). Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE. Journal of Nuclear Medicine. 56(2). 177–182. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johanna Svensson Breakdown of academic impact, for papers by A. Runz Breakdown of academic impact, for papers by Elisa Grassi Breakdown of academic impact, for papers by Emilio Mezzenga Breakdown of academic impact, for papers by Pablo Mínguez Gabiña Breakdown of academic impact, for papers by David Barker Breakdown of academic impact, for papers by Helena Uusijärvi Breakdown of academic impact, for papers by Lore Santoro Breakdown of academic impact, for papers by Türkay Toklu Breakdown of academic impact, for papers by Claudia Brogsitter
Rankless by CCL
2026